RENTSCHLER BIOTECH GMBH has a total of 33 patent applications. Its first patent ever was published in 1988. It filed its patents most often in EPO (European Patent Office), Israel and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are MOGAM BIOTECH RES INST, CAI ZELING and TAIGA BIOTECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Israel | 5 | |
#3 | Australia | 4 | |
#4 | Canada | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Japan | 2 | |
#7 | United States | 2 | |
#8 | Brazil | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Fermentation | |
#6 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | Siklosi Thomas | 9 |
#2 | Hofer Hans | 8 |
#3 | Schroeder Peter | 8 |
#4 | Rehberger Bernd | 7 |
#5 | Wagner Roland | 7 |
#6 | Heine Markus | 7 |
#7 | Wodarczyk Claas | 6 |
#8 | Dierich Manfred P | 5 |
#9 | Tschoepe Michael | 5 |
#10 | Brzoska Josef | 4 |
Publication | Filing date | Title |
---|---|---|
EP2439276A1 | Method for semi-synthetic production of extremely pure minicircle DNA vectors from plasmids | |
AU9627698A | Liquid interferon-beta formulations | |
US6140043A | Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the IFN-receptor and means for diagnosis of an HIV infection | |
EP0704220A1 | Use of medicine containing beta interferon |